41 results
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
several functions: to shield the brain from toxic substances (including viruses, bacteria and other foreign substances including many drugs
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
24 Oct 23
Regulation FD Disclosure
4:18pm
the brain from toxic substances (including viruses, bacteria and other foreign substances including many drugs); to supply brain tissues with nutrients
8-K
EX-10.1
iiqb0ej
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.1
5vlloo416qrgezdduwx
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
c4wnm5lib e4
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
254ejq mt
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
j38jx6i7fi1wlg0
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
f2q meyyq7hojhu7ji
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
t755a
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
qm5bocevbpcotqn6sra8
7 Apr 22
Prospectus supplement
4:46pm
S-3
n4mwc xcieyw54hte7
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
ss2cp
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
8a2r6nbpyyo0r
24 Sep 21
Annual report
7:31am
10-K
dx8 q7q4d1horsufeor4
24 Sep 21
Annual report
7:31am